MedTrace Logo

First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

NCT05460780 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-20

No results posted yet for this study

Summary

This study is a first in human, two-stage single arm non-comparative study of safety and performance.

The aim of the study is to asses the safety and the clinical performance of a new device : the MATTISSE tissu engineering chamber.

Conditions

  • Breast Cancer Female
  • Breast Cancer Prevent
  • Breast Reconstruction

Interventions

DEVICE

MATTISSE TEC

Tissue engineering chamber MATTISSE

Sponsors & Collaborators

  • Lattice Medical

    collaborator UNKNOWN

  • Quanta Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2027-07-31
Completion
2028-12-31

Countries

  • France
  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05460780 on ClinicalTrials.gov